iiinova — where your digital self keeps evolving

Reposted by Alexander Light

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · 18/06/2025

[4/8] 🦆The TRANSFORM team @nikhilmayor.bsky.social, Fran Rawlins, @ajwlight.bsky.social @philmcnamee.bsky.social @ip-london.bsky.social helped supporters of all ages understand how we’re working to find the best way to screen men for #ProstateCancer.

Dr Nikhil Mayor, Fran Rawlins, Dr Alexander Light and Dr Phil Mcnamee with a TRANSFORM leaflet, and children playing the team's hook-a-duck game, designed to illustrate how a screening trial for prostate cancer could work.

101

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 27/04/2025

5yr outcomes following Rezum for >80mL prostates presented by @ajwlight.bsky.social (on behalf of Yan Leung) #AUA25 🇺🇸 Take home message - 3 of 4 patients were free of retreatment by 5 years

012

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 27/04/2025

@ajwlight.bsky.social presents preliminary validation data on the #TARGET scoring system - good specificity and NPV for detecting GG2+ in-field disease Watch this space for our definitive multi centre validation study! #AUA25 🇺🇸

012

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 29/04/2025

Update of #IP7PACIFIC presented by @ajwlight.bsky.social at #AUA25 🇺🇸 This will be the first trial to provide definitive evidence comparing bpMRI vs mpMRI, alongside fusion vs cognitive biopsy >1200 patients recruited across the UK - watch this space

122

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 21/03/2025

Is bpMRI non-inferior to mpMRI? Is image-fusion biopsy superior to cognitive biopsy? @nikhilmayor.bsky.social gives an update on the #IP7PACIFIC trial with >1,000 patients recruited so far #EAU25 🇪🇸

0114

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 21/03/2025

Next is Dr Archana Gopalakrishnan discussing the #IP9ATLAS trial For active surveillance, is regular MRI superior to standard care for detecting progression? Recruitment is open and the trial will randomise 1263 patients in 30 centres. Watch this space! #EAU25 🇪🇸

032

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 21/03/2025

Next up: PhD Fellow @ajwlight.bsky.social presents an update from the multicentre blinded #IP8FLUORESCE study evaluating #ConfocalMicroscopy for margin status in #RadicalProstatectomy - recruitment complete and results out on Monday 24/03 at #EAU25 🇪🇸

043

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 21/03/2025

It’s a big first day at #EAU25 for our clinical trials & PhD fellows! 🚀 Come along at 15:15 to ‘On the horizon: Ongoing trials in urology’ in Green Area Retiro @nikhilmayor.bsky.social presenting #IP7PACIFIC @ajwlight.bsky.social presenting #IP8FLUORESCE Archana Gopalakrishnan presenting #IP9ATLAS

022

Alexander Light @ajwlight.bsky.social · 19/11/2024

Exciting times on a new platform! Looking forward to connecting and collaborating with everyone and seeing the prostate cancer community thrive

010

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 19/11/2024

The protocol paper for the IP8-FLUORESCE trial is now published #openaccess in @bjuijournal.bsky.social ! Excellent work led by Nikhil Mayor and Matt Winkler Keep tuned for the results! Read for free: buff.ly/48ZquK5

184

Reposted by Alexander Light

Imperial Prostate @ip-london.bsky.social · 15/11/2024

It was a record meeting for Imperial Prostate at #BAUSOncology 2024 with presentations on prostate cancer screening, early detection, molecular imaging and discussion of many of our ongoing/upcoming trials from our fellows, lecturers, and consultants #ATLAS #AVIDITY #FLUORESCE #PACIFIC #TRANSFORM

095